ImpediMed Limited

IPDQF · OTC
Analyze with AI
6/30/2025
6/30/2024
6/30/2023
6/30/2022
Operating Activities
Net Income$0-$19,790-$20,521-$19,874
Dep. & Amort.$0$0$2,467$2,769
Deferred Tax$0$0-$754-$3,002
Stock-Based Comp.$0-$680$754$3,002
Change in WC$0$0$86-$1,179
Other Non-Cash-$14,645$2,681-$835-$382
Operating Cash Flow-$14,645-$17,789-$18,049-$15,664
Investing Activities
PP&E Inv.-$60-$81-$6,043-$5,221
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$929-$3,024-$5,651-$5,161
Investing Cash Flow-$989-$3,105-$6,043-$5,221
Financing Activities
Debt Repay.$15,967$0$0$0
Stock Issued$0$58$28,506$42,503
Stock Repurch.$0-$62$0-$2,213
Dividends Paid$0$0$0$0
Other Fin. Act.-$2,325-$477-$574-$373
Financing Cash Flow$13,642-$481$27,932$39,917
Forex Effect-$457$297$1,140$2,017
Net Chg. in Cash-$2,449-$21,078$4,980$21,049
Supplemental Information
Beg. Cash$24,632$45,710$40,730$19,681
End Cash$22,183$24,632$45,710$40,730
Free Cash Flow-$15,634-$20,894-$24,092-$20,885